ACAD SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of …


Levi & Korsinsky, LLP has commenced an investigation of ACADIA Pharmaceuticals Inc. (ACAD) in connection with possible violations of federal securities laws.

To get more information, click here: There is no cost or obligation to you.

On March 11, 2015, the Company announced it would delay submitting a New Drug Application for its drug Nuplazid. The Company also noted that Chief Executive Officer Uli Hacksell is retiring. Shares of ACADIA were down more than 20% on intraday trading the following day.

If you own common stock in ACADIA and wish to obtain additional information about the investigation, please contact Eduard Korsinsky, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Source Article from

This entry was posted in News & Info. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *